Announced positive top-line results from our Phase 2 proof-of-concept clinical trial of PSX-001, known as the PsiGAD1 study, in which synthetic psilocybin in combination with psychotherapy was ...
Emotion regulation and pain catastrophizing influenced pain severity and interference in patients taking opioid medications for chronic noncancer pain.